Literature DB >> 14617316

Antibodies to high-frequency antigens may decrease the quality of transfusion support: an observational study.

Axel Seltsam1, Franz F Wagner, Abdulgabar Salama, Willy A Flegel.   

Abstract

BACKGROUND: There is only little information on the transfusion support of patients with antibodies to high-frequency RBC antigens. STUDY DESIGN AND METHODS: In cooperation with reference laboratories and transfusion services in Austria, Germany, and Switzerland, the transfusion support provided to hospitalized patients identified as having such antibodies was reviewed during a 20-month period.
RESULTS: A total of 52 patients with antibodies to high-frequency antigens were treated in hospitals. Twenty-two of them received 104 units of antigen-negative RBCs. In 23 cases, a deviation from the standard transfusion policy (e.g., transfusion of antigen-incompatible units) occurred. The use of frozen or fresh units varied amongst the different countries but did not affect the rate of deviation from protocol. About 20 percent of all units were supplied internationally. Four antibody specificities, anti-Kpb, anti-Vel, anti-Lub, and anti-Yta, were identified in two-thirds of the patients.
CONCLUSION: This survey indicated that transfusion support was unsatisfactory in about one-third of the hospitalized patients with antibodies to high-frequency antigens. Maintaining a rapidly accessible stock of just four types of rare blood units would ensure adequate transfusion support for most of these patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14617316     DOI: 10.1046/j.1537-2995.2003.00565.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  16 in total

1.  Screening Donors for Rare Antigen Constellations.

Authors:  Franz F Wagner
Journal:  Transfus Med Hemother       Date:  2009-05-26       Impact factor: 3.747

2.  Strategies for the transfusion of subjects with complex red cell immunisation: the Bank of rare blood donors of the Region of Lombardy.

Authors:  Fernanda Morelati; Piera Arnaboldi; Fiorella Barocci; Umberto Bodini; Elisa Boiani; Susanna Bresciani; Giuseppe Cambiè; Giovanni Cazzaniga; Ernesto Cocco; Alessandro Copeta; Massimo Crotti; Francesco D'Agostino; Marco D'Agostino; Valeria Focchiatti; Elena Fonti; Luigi Galassi; Giambattista Gazzola; Luigi Gelpi; Noemi Greppi; Giovanni Battista Inghilleri; Paola Isernia; Maria Cristina Manera; Mirella Marini; Rosalia Monti; Rino Morales; Gianalessandro Moroni; Enrica Morra; Maria Paola Pau; Cinzia Paccapelo; Pasqualepaolo Pagliaro; Daniele Prati; Nicoletta Revelli; Claudia Rinaldini; Davide Rossi; Fabio Rossi; Laura Salvaneschi; Luca Sciariada; Pierluigi Sergiacomo; Alessandra Tiburzi; Roberta Trotti; Rosalia Turdo; Claudio Velati; Maria Antonietta Villa; Giuseppina Vismara; Elisabetta Vitali; Maurizio Marconi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

Review 3.  DGTI Register of Rare Donors.

Authors:  Hein Hustinx
Journal:  Transfus Med Hemother       Date:  2014-09-15       Impact factor: 3.747

4.  Transfusion support during childbirth for a woman with anti-U and the RHD*weak D type 4.0 allele.

Authors:  Q Yin; K Srivastava; D G Brust; W A Flegel
Journal:  Immunohematology       Date:  2021-03

5.  Molecular Bases and Genotyping for Rare Blood Types.

Authors:  Christof Jungbauer
Journal:  Transfus Med Hemother       Date:  2009-05-26       Impact factor: 3.747

6.  Integration of red cell genotyping into the blood supply chain: a population-based study.

Authors:  Willy A Flegel; Jerome L Gottschall; Gregory A Denomme
Journal:  Lancet Haematol       Date:  2015-07       Impact factor: 18.959

7.  Homozygosity for a null allele of SMIM1 defines the Vel-negative blood group phenotype.

Authors:  Jill R Storry; Magnus Jöud; Mikael Kronborg Christophersen; Britt Thuresson; Bo Åkerström; Birgitta Nilsson Sojka; Björn Nilsson; Martin L Olsson
Journal:  Nat Genet       Date:  2013-04-07       Impact factor: 38.330

Review 8.  Red Cell Transfusions in the Genomics Era.

Authors:  Jamal H Carter; Willy A Flegel
Journal:  Semin Hematol       Date:  2019-11-08       Impact factor: 3.851

9.  Transfusion Support in Patients with Hematologic Disease: New and Novel Transfusion Modalities.

Authors:  Sandhya R Panch; Bipin N Savani; David F Stroncek
Journal:  Semin Hematol       Date:  2019-10       Impact factor: 3.851

10.  Canine Dal blood type: A red cell antigen lacking in some Dalmatians.

Authors:  Marie-Claude Blais; Lisa Berman; Donna A Oakley; Urs Giger
Journal:  J Vet Intern Med       Date:  2007 Mar-Apr       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.